Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The CSL Ltd (ASX:CSL) share price has dropped 3% after the company revealed its HY24 result which included good profit growth.
The CSL Limited (ASX:CSL) share price is down after the biotech healthcare giant announced the disappointing result of its CSL112 trial.
The benchmark S&P/ASX 200 (INDEXASX: XJO) index fell 21.7 points, or 0.3 per cent, to 7393.1, with five of the 11 sub-sectors retreating. The broader All Ordinaries (INDEXASX: XAO) shed 24.6 points, also 0.3 per cent, to 7,622.
Weaker iron ore prices saw BHP Group Ltd (ASX: BHP) shed 53 cents, or 1.1 per cent, to $47.18, while Rio Tinto Ltd (ASX: RIO) lost 83 cents, or 0.6 per cent, to $128.32, and Fortescue Ltd (ASX: FMG) eased 13 cents, or 0.5 per cent, to $27.24.
The Resmed CDI (ASX:RMD) share price is down around 13.1% since the start of the 2024. It’s probably worth asking, ‘is the RMD share price top value?’
The CSL Limited (ASX:CSL) share price is up 2.6% since the start of the 2024. It’s probably worth asking, ‘is the CSL share price good value?’
The Resmed CDI (ASX:RMD) share price has decreased 12.7% since the start of the 2024. It’s probably worth asking, ‘is the RMD share price good value?’
The CSL Limited (ASX:CSL) share price has risen 2.2% since the start of the 2024. It’s probably worth asking, ‘is the CSL share price top value?’
The Resmed CDI (ASX:RMD) share price is down around 19.6% since the start of the 2024. It’s probably worth asking, ‘is the RMD share price top value?’
